Both in Pharmaceuticals
Jazz Pharmaceuticals vs BioMarin Pharmaceuticals
Over the past year JAZZ returned +66.0% and BMRN returned +5.3%; their daily moves had a correlation of 0.16.
JAZZ +66.0% BMRN +5.3%Growth of $1, one year, split-adjusted
| Metric | JAZZ | BMRN |
|---|---|---|
| Price | $229.74 | $55.66 |
| Market cap | $14.91B | $10.77B |
| Today | +7.13% | −3.10% |
| 1 month | −2.7% | −3.3% |
| 6 months | +8.2% | +4.5% |
| Year to date | +35.1% | −6.3% |
| 1 year | +66.9% | +3.9% |
| Revenue growth (YoY) | +10.4% | +19.9% |
| Gross margin | 91.1% | 79.5% |
| Net margin | −38.9% | 4.5% |
| P/E (TTM) | 72.4× | 147.7× |
| Price / sales | 3.2× | 3.2× |
| Net cash | -$2.71B | -$3.31B |
| Dividend yield | — | — |
| Volatility (60d) | 31.5% | 26.7% |
| Short % of float | 9.4% | 6.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).